Currently, no neuroprotective therapies have been shown to reduce the secondary neuronal damage occurring after traumatic brain injury. Recent studies have addressed the potentiality of hyperoxia to ameliorate brain metabolism after traumatic brain injury. In this article, we present the principles of oxygen transport to the brain, the effects of hyperoxia on cerebral metabolism, and the role of lactate in brain metabolism after traumatic brain injury.
Introduction
Traumatic brain injury (TBI) is associated with primary injury (owing to the biomechanical effects of the impact) and with secondary or delayed vascular, metabolic, cellular, and molecular events that are initiated minutes after the injury and last as long as several months [1, 2] . The secondary processes activated by the trauma interact in a complex network leading to cell dysfunction, death, and/or recovery of neurologic function. During the past 10 years, the application of imaging techniques such as MRI, spectroscopy, and positron emission tomography; the use of invasive focal continuous monitoring tools such as microdialysis and probes to measure brain tissue oxygen tension (PtiO 2 ); and advanced histologic and molecular biology techniques led scientists and clinicians to an increased understanding of the mechanisms underlying secondary neuronal damage after TBI. Topics of continuing interest and recent debate are the posttraumatic alterations in brain metabolism/oxygenation and the potential of hyperoxia as therapeutic tool for TBI.
Principles of oxygen delivery to the brain
Oxygen transport to the tissues depends on the respiratory and circulatory systems and on local vascular factors. Oxygen is transported from alveolar air to blood, from blood to peripheral tissues, and finally to the mitochondria by diffusion steps. Oxygen is transported in the blood mostly bound to hemoglobin, and the oxygencarrying capacity is largely dependent on the hemoglobin concentration; in contrast, the dissolved oxygen is negligible. At the microvascular level, oxygen diffusion is mostly dependent on the tension gradient between the vessels and the tissue (ultimately mitochondria) and is inversely related to the diffusion distance (Fick first law of diffusion). Mitochondria need an intracellular oxygen tension Ն1.5 mm Hg for oxidative metabolism; however, the PtiO 2 threshold required to provide sufficient intracellular oxygen is still unclear [3••] .
Cerebral response to hyperoxia
The cerebrovascular response to hyperoxia has been investigated in physiologic and pathologic conditions, and it has been shown that there is a cerebral blood flow (CBF) reduction in response to hyperoxia ranging from 9% to 27% [4•]. Menzel et al. [5] studied the cerebral oxygen vasoreactivity in six patients after TBI using stable xenon CT. In regions of interest corresponding with normal-appearing tissue, they observed a mean CBF reduction of 19%. The degree of this response was proportional to the level of the regional baseline CBF.
Hyperoxia is followed by an increase in blood oxygen saturation measured in the jugular bulb [6] and by a decrease in arteriovenous oxygen difference (AVDO 2 ) [7••] , suggesting that the ratio between oxygen demand and supply is shifted either to a lower cerebral metabolic rate of oxygen consumption or to a better oxygen delivery. However, in a swine model of progressive global brain ischemia, it has been shown that when CBF is reduced to 30%, AVDO 2 is not changed by hyperoxia, suggesting that increasing PaO 2 does not always influence brain oxygen delivery [8] .
Brain tissue oxygen tension can be measured using sensors placed in the brain parenchyma; PtiO 2 is a measurement of the mean tissue oxygen tension over a volume of few cubic millimeters that contains extracellular fluid, capillaries, cells, and axons [9] . There is a good correlation between CBF and PtiO 2 [10] , and one advantage of this monitoring is the possibility of detecting changes in regional brain oxygenation that would otherwise be missed by measuring the blood oxygen saturation in the jugular bulb [11] . In addition, PtiO 2 normally has a linear relationship to PaO 2 and hyperoxia leads to an increase in brain oxygenation. It has been shown that baseline PtiO 2 values and response to hyperoxia are higher when the probe is placed in normal-appearing tissue on the CT scan compared with when it is placed around a cerebral contusion. These findings suggest that oxygen diffusion from the vasculature to the tissue might be reduced as a result of pathologic changes such as cellular swelling or microscopic arteriovenous shunts directing flow away from the capillaries [12] .
Rationale for hyperoxia therapy in traumatic brain injury
Hypoperfusion and ischemia are common mechanisms of secondary damage after TBI that are known to exacerbate the effects of the primary mechanical insult [13, 14] . It is therefore clear that the management of TBI patients in the ICU should be focused on the prevention, detection, and correction of inadequate oxygen and substrate delivery to the brain [15] . Brain metabolism is changed by trauma, and schematically there is a biphasic behavior:
1. The injury itself induces a massive efflux of potassium from the cells and release of excitatory amino acids [16•]. To restore transmembrane ionic gradients, cells respond by increasing glucose utilization. Cerebral oxidative metabolism normally runs near maximal capacity; therefore, acute increases in energy demand necessarily require increases in glycolysis, leading to lactate accumulation [17,18,19••,20•] .
In this setting of greater demand, impaired supply of oxygen and substrates, caused by a decrease in CBF, although not to ischemic levels, may become an important factor in delayed injury. Using microdialysis, both ischemia and hyperglycolysis are characterized by decreased extracellular glucose concentration and increased lactate concentration and ratio between lactate and pyruvate (even if the mechanisms are different) [21] . Extracellular lactate accumulation can represent a spectrum ranging from compensatory hyperglycolysis to anaerobic glycolysis from profound oxygen depletion: in the latter case, treatments that improve the oxygen availability to the mitochondria might be useful in correcting the underlying metabolic disorder and lowering the lactate concentration. 2. Subsequently, there is a phase characterized by a reduction of glucose and oxidative metabolism that lasts for days to weeks [18,20•,22••] . The condition in which the decrease in the cerebral metabolic rate of oxygen consumption is greater than the decrease in glucose metabolism is called relative hyperglycolysis, and it has been shown to occur in 83% of severely brain-injured patients during the first 5 days postinjury. In this period, the cerebral metabolic rate of oxygen consumption was decreased in 97% of measurements and was shown to be an independent predictor of outcome at 6 months postinjury [19••] . In this scenario, the hypothesis underlying the application of hyperoxia after TBI is that the increased PtiO 2 could increase oxidative metabolism by improving the Krebs cycle enzyme function or oxidative phosphorylation.
Hyperbaric oxygen in traumatic brain injury
Hyperbaric oxygen (HBO) therapy is the administration of oxygen at a pressure greater than the atmospheric pressure at sea level (or 1 atm). Its effect consists of an increase PaO 2 in the blood and tissues. After hemoglobin is fully saturated, further increases in PaO 2 can increase only the amount of oxygen physically dissolved in the plasma. As the PaO 2 increases in the inspired air, the amount of oxygen dissolved in the plasma increases linearly. For every atmosphere of pressure increase, 1.8 mL of oxygen/100 mL of blood is dissolved in the plasma [23] . Compared with eubaric oxygenation, HBO induces a much greater increase in the oxygen-carrying capacity and dramatically increases the driving force of oxygen diffusion.
Few studies have investigated the effects of HBO in the treatment of TBI: Rockswold et al.
[24] enrolled 168 severely head-injured patients. They were randomized to receive either standard care or standard care plus HBO therapy at 1.5 atm. Patients were followed for 12 months, and functional recovery was assessed by masked examiners using the Glasgow Outcome Scale. Overall, mortality in treatment and control groups was not significantly different. The authors identified a subgroup of patients for whom HBO therapy was associated with a lower mortality rate; however, this treatment was not associated with an increase in favorable outcomes among survivors. These data were further supported by a recent review of the literature that does not support the use of HBO therapy for TBI [25] .
In addition, Rockswold et al. [26] investigated the effects of HBO therapy at 1.5 atm on CBF and metabolism. The authors observed that at 1 and 6 hours post-treatment, there was an increase in CBF in the group with decreased baseline values, whereas there was a decrease in CBF in the patients with increased pretreatment values.
Patients with CBF within the normal range showed similar values before and after exposure to HBO. In contrast, AVDO 2 was unaffected by the treatment when measured at the same time points. The reason for this variable cerebrovascular response to the HBO remains unclear, and definite conclusions cannot be drawn because Watson et al. [27] showed that the effect of hyperoxia on CBF is transient and disappears within minutes after discontinuation of hyperoxia. None of the patients in the study showed values suggestive of ischemia; therefore, from these data, it is still unclear whether HBO therapy can be an option to restore brain oxygenation in presence of brain ischemia.
Eubaric oxygen in traumatic brain injury
In the ICU, eubaric hyperoxia is easily and quickly obtained by increasing the fraction of inspired oxygen of the mechanical ventilator. Three papers evaluated the metabolic effects of hyperoxia in patients after TBI. Menzel et al. [28••] induced hyperoxia over a period of 6 hours by raising the fraction of inspired oxygen from 35% to 60% and finally to 100% during the first 24 hours post-injury in a cohort of 12 patients and compared the intracranial/metabolic effects with those of a control cohort of well-matched patients. Hyperoxia did not have any effect on intracranial pressure and cerebral perfusion pressure. PtiO 2 increased in all the oxygen-treated patients. Interestingly, patients subjected to hyperoxia showed a 40% decrease in lactate by the end of the oxygen treatment. In contrast, the levels of glucose did not show a clear trend during the oxygen enhancement period. These data suggest that hyperoxia reduces lactate concentration after TBI. More recently, Reinert et al. [29••] extended the findings of Menzel et al. in 15 patients. However, because the authors of both studies did not include data regarding the blood oxygen saturation in the jugular bulb and the AVDO 2 and lactate/pyruvate ratio (a better estimator of the cellular redox state), it is still unclear weather hyperoxia may really improve oxygen delivery to an ischemic brain or increase oxidative metabolism.
Magnoni et al. [7••] tested the hypothesis that hyperoxia could improve oxidative metabolism after TBI by evaluating the lactate/pyruvate ratio. In eight patients subjected to 18 tests, they observed that 3 hours of hyperoxia were followed by a significant decrease in lactate concentration in the extracellular space, but because pyruvate slightly decreased also, the ratio between the two metabolites did not change. The effect of hyperoxia was transient, and lactate returned close to the baseline value after the end of the hyperoxygenation period. AVDO 2 and baseline values of lactate and the lactate/pyruvate ratio were in the normal range, indicating that the tests were not performed in the presence of global and/or regional ischemia. These data suggest that in a condition of a sufficient oxygen supply, hyperoxygenation does not change oxidative metabolism after TBI. A debate has been recently opened after the publication of these data, and the interpretation of the hyperoxia-mediated reduction in AVDO 2 , lactate, and pyruvate associated with no changes in the glucose extracellular concentration remains unclear [30] . The hypothesis that increasing oxygen tension at the cellular level can be beneficial might be true in ischemia, in which the problem is the decrease in oxygen availability for oxidative metabolism. In fact, in a model of focal ischemia in rats, hyperoxia attenuated neurologic deficits at 24 hours after injury and decreased the histologic damage at 2 weeks post-ischemia [31] . However, even if ischemia and TBI coexist, TBI has a more complex pathophysiology and mitochondrial alterations occur even in presence of an adequate CBF.
Controversies Lack of evidence to support the hypothesis that hyperoxia would improve mitochondrial function
It has been shown that experimental and clinical TBI results in mitochondrial dysfunction and damage [32, 33] . Mitochondria play a major role in the progression of posttraumatic secondary damage and may represent the final common pathway after excitotoxicity, Ca 2+ overload, oxidation, energy failure, and apoptosis [34] . Xiong et al.
[33], after controlled cortical impact brain injury in rats, documented a decreased (nearly 50%) state 3 respiratory rate, phosphorylation of ADP/oxygen (P/O) ratio, and respiratory control index as early as one hour postinjury and lasting for 14 days. The authors reported an increase in the amount of mitochondrial Ca 2+ , particularly in the injured hemisphere starting 6 hours post-injury. Intramitochondrial Ca 2+ accumulation impairs the electron transport chain leading to reduced ATP production and generation of reactive oxygen species, which can lead to cell death through energy failure and oxidative damage. Mitochondrial Ca 2+ loading is also responsible for a nonselective increase in the permeability of the inner mitochondrial membrane called mitochondrial permeability transition megapore [35] . Recently, Lifshitz et al. [36•] studied the mitochondrial morphology and function after lateral fluid percussion brain injury in rats: Electron microscopy analysis of injured mitochondria revealed a variety of mitochondrial sizes, shapes, and internal struc-tures such as disrupted cristae, thinned outer membranes, and a swollen appearance. The study supported the hypothesis that Ca 2+ -induced swelling in mitochondria isolated from injured brain is predominantly mediated through regulated mitochondrial permeability transition, and this swelling might lead to mitochondrial membrane rupture. Finally, the study showed also that in the central nervous system, there are mitochondrial populations that are different in terms of sensitivity to injury and Ca 2+ loading. More work needs to be done to clarify the pathophysiology of mitochondrial/brain metabolism alterations to test new therapeutic strategies aimed at reducing secondary damage after TBI.
Role of lactate after traumatic brain injury
Lactate has been shown to increase after TBI in animal models and in the clinical setting [37, 38] . Goodman et al.
[39•] observed in 126 brain-injured patients that lactate concentration was significantly greater in the patients who died than in those who survived, and this difference occurred primarily in the first 36 hours. However, the role of increased lactate concentration after TBI should be reassessed because it might be a marker of injury severity, but it is still unclear whether it is intrinsically harmful to the brain. There is emerging evidence to revise the hypothesis that glucose is the sole energy substrate used by adult brain cells to sustain neural activity. According the astrocyte-neuron lactate shuttle hypothesis (for a more comprehensive discussion, see [40••,41 ••]), there is an increase in aerobic glycolysis in astrocytes in response to neural activation at glutamatergic synapses (characterized by glucose use and lactate production despite sufficient oxygen levels to support oxidative phosphorylation). Lactate might then be oxidized and used as energy substrate by the neurons. Rice et al. [42] observed that the administration of lactate 30 minutes after fluid percussion brain injury in rats attenuated cognitive deficits observed at days 11-15 postinjury, suggesting a protective role of lactate after TBI. Recently, in a cohort of 49 brain-injured patients subjected to 179 determinations of lactate metabolism over the first 5 days, it was shown that cerebral lactate uptake occurred in 76% of them and in 44% of the measurements. Abnormal uptake of lactate by the brain (cerebral metabolic rate of lactate >97.5th percentile of normal) was observed in 28% of measurements; in contrast, abnormal lactate production by the brain occurred in only 2% of studies. Patients with a favorable outcome showed a greater brain lactate uptake when compared with patients with an unfavorable outcome [19••] . These data suggest that lactate can be effectively used as substrate by the injured brain and that therapeutic strategies aimed at reducing lactate concentration after TBI should be reevaluated.
Conclusion
To date, no neuroprotective therapies have been shown to reduce the secondary neuronal damage occurring after TBI. Hyperoxia would be a simple and relatively safe procedure. At present, there is no evidence to support any clinical benefit of hyperoxia in brain-injured patients. Further work is needed in well-designed, controlled, preclinical conditions evaluating its effects on posttraumatic mitochondrial pathology, brain metabolism, behavioral, and histologic outcomes before planning any clinical trial.
